
PATENTS:​ Granted:
1. Avinash Sonawane and Ranjit Mehta. Novel asparaginase mutants for acute lymphatic leukemia treatment (Indian Patent grant No. 365651)
2. Venkatesh Chelvam, Premansh Dudhe, Mena Asha Krishnan and Avinash Sonawane. Metal-free, solvent-free synthesis of fused-pyridoheterocycles: Biological efficacy against cancer and multi-drug resistant pathogens. ( Indian Patent grant No. 36698)
3. Venkatesh Chelvam, Premansh Dudhe, Mena Asha Krishnan and Avinash Sonawane. Metal-Free Solvent-Free Synthesis of Fused Pyrido Heterocycles and Biomedical Applications (US Patent Grant No. 11,427,596 )
Filed:
1. Avinash Sonawane, Mainak Biswas, Soumika Sengupta and Vikram Gota (2021). E. Coli l-asparaginase variant for the treatment of acute lymphoblastic leukemia (ALL). (Patent Application Number: TEMP/E-1/49296/2021-MUM)
2. Avinash Sonawane and Ranjit Mehta (2015). Thermostable Escherichia coli L-asparaginase II and its use as food additive to reduce acrylamide formation (Patent Application No: 1302/KOL/2014).
3. Avinash Sonawane, Rojalin Sahu and Rashmirekha Pati (2015). Novel therapeutic nanoparticle conjugates for the treatment of tuberculosis (Patent Application No: 32881/KOL/2014).​​
​
BOOK CHAPTERS:​
-
Biplab Sarkar and Avinash Sonawane (2023). Biological Applications of Nanoparticles. Springer Nature Published (DOI: 10.1007/978-981-99-3629-8).
-
Behera A, Biswas M, Ergün S, Karnati S, Sonawane A. Detection of Peroxisomal Proteins During Mycobacterial Infection. InPeroxisomes: Methods and Protocols 2023 Mar 24 (pp. 123-134). New York, NY: Springer US.
-
Avinash Sonawane (2020). Adding to the arsenal: targeting human proteins for controlling M. tuberculosis growth. Drug Target Review. Volume 3, Issue 7
-
Avinash Padhi and Avinash Sonawane (2021). Host Directed Therapy for Tuberculosis, Spinco Biotech Cutting Edge, June 2021 issue
-
Avinash Sonawane and Soumitra Mohanty (2014). Recent advances in pathogenesis, Control and Prevention of Tuberculosis. Advances in Biochemistry and Biotechnology, Volume 2, page 143-162, Daya Publishing House.
​​​
​
SCIENTIFIC MEETING PUBLICATIONS:​ 1. Manaswini Jagadev and Sonawane A. (Feb. 29-March 2, 2020). Identification and evaluation of peptide based vaccine candidates from Mycobacterium tuberculosis genome. ICDD Conference, Hyderabad.2. Biswas, M., Sengupta, S., Gota, V. and Sonawane, A. (Feb 7-9, 2020). Development and evaluation of novel E.coli L- asparaginase (EcA) mutants for the treatment of acute lymphatic leukaemia (ALL). International Conference on Emerging Areas in Biosciences and Biomedical Technologies-2 (eBBT-2). Indian Institute of Technology (IIT) Indore, India.3. Behera, A., Ganguli, G. and Sonawane, A. (Feb 7-9, 2020). Role of novel mycobacterial acetyltransferase in suppressing oxidative stress by inducing peroxisome formation in macrophages. International Conference on Emerging Areas in Biosciences and Biomedical Technologies-2 (eBBT-2). Indian Institute of Technology (IIT) Indore, India.4. Sengupta, S. and Sonawane, A. (Feb 7-9, 2020). Mycobacterium tuberculosis phosphoribosyltransferase inhibits autophagy by inducing histone hypermethylation in macrophages. International Conference on Emerging Areas in Biosciences and Biomedical Technologies-2 (eBBT-2). Indian Institute of Technology (IIT) Indore, India.5. Jagadeb, M. and Sonawane, A. (Feb 7-9, 2020). Computational screening of phytochemicals to identify potent cell wall inhibitors against Mycobacterium tuberculosis. International Conference on Emerging Areas in Biosciences and Biomedical Technologies-2 (eBBT-2). Indian Institute of Technology (IIT) Indore, India.6. Das, I. and Sonawane, A. (Feb 7-9, 2020). Role of telomerase in developement of chronic Mycobacterium tuberculosis infection. International Conference on Emerging Areas in Biosciences and Biomedical Technologies-2 (eBBT-2). Indian Institute of Technology (IIT) Indore, India.7. Pattanaik, K. and Sonawane, A. (Feb 7-9, 2020). Recombinant EcxL of Mycobacterium tuberculosis stimulates TNF- alpha secretion in RAW 264.7 macrophages through activation of MAPK and NF-KB pathway via TLR2. International Conference on Emerging Areas in Biosciences and Biomedical Technologies-2 (eBBT-2). Indian Institute of Technology (IIT) Indore, India.8. Ganguli, G. and Sonawane, A. (Feb 7-9, 2020). Mycobacterium tuberculosis ACTase regulates peroxisome homeostasis to control redox levels in infected macrophages. International Conference on Emerging Areas in Biosciences and Biomedical Technologies-2 (eBBT-2). Indian Institute of Technology (IIT) Indore, India.9. Sengupta, S., Biswas, M., Gandhi, K., Gota, V. and Sonawane, A. (june 13-16, 2019) .In vitro and in vivo studies of novel asparaginase mutants for the treatment of acute lymphatic leukaemia. 24th Congress of European Hematology Association held in Amsterdam, Netherlands.10. Naik, SK., Pattanaik, K., Eich, J., Hauptmann, M., Schaible, UE. and Sonawane, A. (September 2-5, 2018). Role of TRPV4 calcium ion channel in immune response against Mycobacterium tuberculosis infection. 5th European Congress of Immunology. Amsterdam, Netherlands.11. Sengupta, S. and Sonawane, A. (2018). Mycobacterium tuberculosis ESAT-6 like protein epigenetically alters antigen presentation by inducing Histone hypermethylation. The 10th Hope meeting with Nobel laureates. Yokohama, Japan.12. Padhi, A. and Sonawane, A. (Dec 11-13, 2017). Mycobacterial lipoprotein mediates bacterial survival by inhibiting antimicrobial peptide secretion and blocking phagosomal maturation pathway. EMBO event on Autophagy: Cellular mechanisms and significance in health and disease in Bhubaneswar. Odisha.13. Jagadeb, M. and Sonawane, A. (Octber 2-4, 2017). High throughput virtual screening to identify a novel inhibitor against Pyrazinamide resistant tuberculosis. NextGen Genomics, Biology, Bioinformatics and Technologies (NGBT) conference. Odisha.14. Sengupta, S., Biswas, M. and Sonawane, A. (Feb 10-11, 2017). Improving the therapeautic efficacy of E. Coli L- asparaginase II used for the treatment of childhood acute lymphatic. 6 th Conference of Molecular Pathology Association of India. Odisha.15. Jagadeb, M. and Sonawane, A. (April 7-9, 2017). In silico analysis to identify novel inhibitors against multi-drug resistant tuberculosis. International Conference on Drug Design. New Delhi.16. Naik, SK., Padhi, A., Ganguli, G., Sengupta, S. and Sonawane, A. (March 22-25, 2017). Bone marrow mesenchymal stem cells kill mycobacteria by inducing the expression of cathelicidin. International Union against Tuberculosis and Lung Disease Asia Pacific Region Conference (APRC). Tokyo, Japan.17. Ganguli, G. and Sonawane, A. (March 2-5, 2016). Mycobacterium tuberculosis inhibits host induced oxidative stress via peroxisome biogenesis. 17th International Congress on Infectious Diseases (ICID). Hyderabad.18. Sengupta, S. and Sonawane, A. (2016), Mycobacterial ESAT-6 like protein alters Antigen Presentation by inducing Epigenetic Modification. 11th Asian Epigenomics meeting held at Jawaharlal Nehru Centre for Advanced Scientific Research ( JNCASR). Bangalore, India.19. Sengupta, S. and Sonawane, A. (2016). Mycobacterium tuberculosis ESAT-6 like protein alters antigen presentation by inducing epigenetic modification. Max Planck Institute of Immunobiology and Epigenetics. Freiburg, Germany.20. Ganguli, G. and Sonawane, A. (October 7-11, 2015). Mycobacterium tuberculosis Acetyltransferase Reduces the Oxidative Stress Response Through Expression of Peroxisomal Membrane Transporter Protein. Infectious Disease Week. San Diego, California.21. Ganguli, G. and Sonawane, A. (2-4th September 2015). Mycobacterium tuberculosis Acetyltransferase reduces the oxidative stress response through expression of peroxisomal membrane transporter protein. 1st International Meeting on Respiratory Pathogens (IMRP). Singapore.22. Padhi, A. and Sonawane, A. (Oct 31-Nov 4, 2014). Investigating role of Putative Peptidoglycan amidase, in biofilm formation and antimicrobial resistance ofMycobacterium tuberculosis. 5th International meeting on Emerging Diseases and Surveillance (IMED). Vienna.​